Your trusted destination for CME, CPD & Medical Education across the Middle East.
Hamad Medical Corporation, Doha, Qatar
Dr. Fawziya Alyafei is a Qatari pediatric endocrinologist and consultant based at Hamad Medical Corporation (HMC), Doha, Qatar. Her clinical and academic work focuses on pediatric endocrinology, childhood obesity, diabetes, growth and puberty disorders, thyroid disease, metabolic disorders, and insulin resistance. Her current professional profile identifies her as a Consultant Pediatric Endocrinologist in the Department of Pediatrics at Hamad General Hospital.
She is also a faculty member of the Qatar Pediatric Endocrine and Diabetes Conference (QPEDC) 2026, where she is scheduled to moderate sessions and contribute to discussions on normal anthropometry in pediatrics and the definition and causes of childhood obesity.
Hamad Medical Corporation (HMC), Doha, Qatar
Department: Pediatrics — Pediatric Endocrinology
Current position: Consultant Pediatric Endocrinologist
Her affiliation with the Division of Endocrinology, Department of Pediatrics, Hamad General Hospital is also documented in peer-reviewed publications.
Dr. Alyafei's documented areas of expertise include:
Her research and conference activity particularly demonstrate a sustained interest in childhood obesity and metabolic health. In 2026, she was among the HMC pediatric endocrinology investigators contributing to research examining the relationship between pediatric obesity and youth-onset type 2 diabetes.
Dr. Alyafei has contributed to research on central precocious/early puberty, including a 2023 review examining the long-term health consequences of early puberty and the effects of treatment with GnRH analogues. The publication lists her affiliation as the Department of Pediatrics, Division of Endocrinology, Hamad General Hospital, Doha, Qatar.
She has also contributed to research examining nutritional stunting and its consequences from childhood into adulthood. The publication includes her among the pediatric endocrinology researchers at Hamad General Hospital.
Her work includes collaborative research on type 1 diabetes in children and adolescents. A 2026 European Journal of Endocrinology abstract on global patterns and determinants of diabetic ketoacidosis at diagnosis of type 1 diabetes lists Alyafei among the investigators from Hamad Medical Center's Pediatric Endocrinology team.
In 2026, she was listed as a co-author on research examining the relationship between pediatric obesity and youth-onset type 2 diabetes, using longitudinal and cross-sectional population-level evidence.
Her earlier academic work also includes pediatric endocrine and metabolic conditions. A conference abstract from the European International Congress of Pediatrics documented her involvement in a case concerning neonatal screening and familial immunodeficiency, demonstrating her broader participation in pediatric clinical research.
Dr. Alyafei has participated in regional and international pediatric endocrinology activities.
A particularly relevant earlier contribution was at the Arab Society for Pediatric Endocrinology and Diabetes (ASPED) / European Society for Paediatric Endocrinology (ESPE) School, where she presented “Polyuria, Polydipsia and Polyphagia is Not Always Diabetes Mellitus.” The presentation discussed central diabetes insipidus in the context of Langerhans cell histiocytosis.
She has also contributed to the wider pediatric endocrine research community through publications and conference abstracts involving obesity, diabetes, growth, puberty and metabolic disorders.
For the Qatar Pediatric Endocrine and Diabetes Conference (QPEDC 2026), Dr. Alyafei is listed as Conference Faculty.
Her listed contributions include:
QPEDC 2026 is scheduled for 27–28 November 2026 in Doha and covers pediatric diabetes, obesity, growth and puberty disorders, thyroid disease and other pediatric endocrine conditions.
| PeriodCareer / Achievement | |
| Earlier career | Developed her clinical career in pediatrics and subsequently specialized in pediatric endocrinology in Qatar. |
| 2010s | Participated in pediatric endocrine and diabetes education/research activities, including ASPED/ESPE educational programs. |
| 2013 | Participated in pediatric research presented through the European International Congress of Pediatrics, including work on neonatal screening and familial immunodeficiency. |
| 2020s | Established a substantial academic/research profile in pediatric endocrinology, with publications involving growth, puberty, obesity, diabetes and metabolic disorders. |
| 2023 | Co-authored research on the long-term health consequences of central precocious/early puberty and GnRH-analogue treatment. |
| 2024–2025 | Continued clinical and academic work within HMC's pediatric endocrinology service. |
| 2026 | Listed as a Consultant Pediatric Endocrinologist at HMC and continued research involving pediatric obesity, diabetes and metabolic disease. |
| 2026 | Joined the QPEDC 2026 faculty, contributing to sessions on pediatric anthropometry and childhood obesity. |
Sidra Medicine
Sidra Medicine